The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 101-59-87
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2024
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Aliev S.A.

Azerbaijan Medical University

Mamedova S.E.

Azerbaijan Medical University

Aliev É.S.

Azerbaijan Medical University

The use of intragastral botulinum toxin in the treatment of patients with morbid obesity: realities and perspectives

Authors:

Aliev S.A., Mamedova S.E., Aliev É.S.

More about the authors

Journal: Endoscopic Surgery. 2021;27(5): 48‑55

DOI: 10.17116/endoskop20212705148

Views: 1042

Downloaded: 29

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Aliev SA, Mamedova SE, Aliev ÉS. The use of intragastral botulinum toxin in the treatment of patients with morbid obesity: realities and perspectives. Endoscopic Surgery. 2021;27(5):48‑55. (In Russ.)
https://doi.org/10.17116/endoskop20212705148

Подписка 2025 (Endoscopic Surgery)
МСФ на ЯМ
Close metadata
Recommended articles:
The first expe­rience of robot-assisted bariatric surgery using the Senhance system in patients with morbid obesity. Piro­gov Russian Journal of Surgery. 2023;(11):82-88
Resu­lts of the first All-Russian consensus conference on bariatric surgery. Piro­gov Russian Journal of Surgery. 2024;(3):87-94
Serum ghre­lin changes after bariatric surgery. Piro­gov Russian Journal of Surgery. 2024;(4):49-54
Non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus. Russian Journal of Evidence-Based Gastroenterology. 2023;(4):103-108
Mole­cular and physiological effe­cts of myo-inositol and its role in the prevention of gestational diabetes mellitus in pregnant women with overweight and obesity. Russian Bulletin of Obstetrician-Gynecologist. 2023;(6-2):120-126
Effi­ciency and safety of electrocoagulation as a means of local hemo­stasis of the staple line in bariatric surgery. Endo­scopic Surgery. 2024;(1):36-42
Psychopharmacotherapy of mixed affe­ctive states in bipo­lar diso­rder. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(2):103-108
Asso­ciations between components of meta­bolic syndrome and cognitive impairment in patients with schi­zophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3):82-87
Cere­bral hemo­dynamic diso­rders in patients with schi­zophrenia with concomitant meta­bolic syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):80-85
Predictors of effe­ctive complex physiotherapy in patients with skin invo­lution. Rege­nerative Biotechnologies, Preventive, Digi­tal and Predictive Medi­cine. 2024;(1):13-20

In this article was given the analytical overview of literature for non-operative treatment of patients with morbid obesity.The results of clinical and experimental investigations of endoscopic using of botulinum toxin with assessment it’s bariatric effectiveness were analyzed. This assessment evidenced for key problems in this pathology. On the other side there are no precise indications and contraindications for the using of botulinum toxin. There are no information about the mechanism of it’s bariatric effect. This way you can see, that to make a decision about the using of botulinum toxin in the treatment of patients with morbid obesity we need more clinical experience and scientific analysis of the results.

Keywords:

morbid obesity
methabolic syndrome
bariatric surgery
botulinum toxin
intragastric injection

Authors:

Aliev S.A.

Azerbaijan Medical University

Mamedova S.E.

Azerbaijan Medical University

Aliev É.S.

Azerbaijan Medical University

Received:

13.01.2021

Accepted:

24.06.2021

List of references:

  1. World Health Statistics 2012. WHO. 2013. (In Russ.).
  2. Ametov AS, Pashkova EYu, Ramazanova ZD, Darsigova MN. Obesity as a non-infections epidemic of the XXI centry. Modern ideas about the pathogenesis, risks and approaches to pharmacotherapy. Endocrinologiya. 2019;8(2):57-66. (In Russ.). https://doi.org/10.24411/2304-9529-2019-12007
  3. Razina AO, Achkasov EE, Runenko SD. Obesity: a modern look at the problem. Ozhirenie i metabolizm. 2016;13(1):3-8. (In Russ.). https://doi.org/10.14341/OMET201613-8
  4. Bulletin of the World Health Organization 2013;91:549550. Date: January 15.2015. (In Russ.). https://doi.org/10.2471/BLT.13.020813
  5. Yashkov YuI, Ershova EV. Metabolic surgery. Ozhirenie i metabolizm. 2011;3:65-68. 
  6. Roberts CK, Hevener AL, Bernard RJ. Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training. Compr Physiol. 2013;3(1):1-58.  https://doi.org/10.1002/cphy.c110062
  7. Eckel RH, Kahn SE, Ferrannini E, Goldfine AB, Nathan DM, Schwartz MW. Obesity and type 2 Diabetes: what canbe unified and what needs to be individualized. J Clin Endocrinol Metab. 2011;96(6):1654-1663. https://doi.org/10.1210/jc.2011-0585
  8. Obesity management for the treatment of type 2 diabetes. American Diabetes Association. 2016;39:7-51.  https://doi.org/10.2337/dc16-s009
  9. Gefalu TW, Bray GA, Home D, Garvey WT, Klein S, Pi-Sunyer FX, Hu FB, Raz I. Advances in the science, treatment and prevention of the Disease of Obesity: reflections from a Diabetes Care Editors Expert Forum. Diabetes Care. 2015;38(8):1567-1582. https://doi.org/10.2337/dc15-1081
  10. Bradshow PT, Monda KL, Stevens J. Metabolic syndrome in healthy obese, overweight and normal weight individuals: the atherosclerosis risk in communities study. Obesity (Silver Spring). 2013;21(1):203-209.  https://doi.org/10.1002/oby.20248
  11. Verbovoy AF, Passhentseva AV, Sharonova LA. Obesity and cardiovascular system. Klinicheskaya meditsina. 2017;95(1):31-35. (In Russ.). https://doi.org/10.18821/0023-2149-2017-95-1-31-35
  12. Druzhilov MA, Druzhilova OYu, Bateleva YuE, Kuznetsova TYu. Obesity as cardiovascular risk factor: accent in quality and functional activity of adipose tissue. Rossiiskii kardiologicheskii zhurnal. 2015;4(120):111-117. (In Russ.).
  13. Nakamura K, Fuster JJ, Walsh K. Adipkines: a link betwen obesity and cardiovascular disease. J Cardiol. 2014;63:250-259.  https://doi.org/10.1016/j.jjcc.2013.11.006
  14. Stanoevich U, Dechissi Eİ, Chhikvadze VD. Kolorektalnyj rak pri ozhirenii: pathogeneticheskie aspekty: Vrach. 2012;8:23-28. (In Russ.).
  15. Guffey CR, Fan D, Singh UP, Murphy EA. Linking obesity to colorectal cancer: recent insights into plansible biological mechanisms. Curr Opin Nutr Metab Care. 2013;16(5):595-600.  https://doi.org/10.1097/MCO.0b013e328362d10b
  16. Bardon M, Barkun AN, Martel M. Obesity colorectal cancer. Gut. 2013;62(6):933-947.  https://doi.org/10.1136/gutjnl-2013-304701
  17. Thourani VH, Keeling WB, Kilgo PD, Puskas JD, Lattouf OM, Chen EP, Guyton RA. The impact of body mass index on morbidity and short and long-term mortality in cardiac valvular surgery. J Thorac Cardiovasc Surg. 2011;142:1052-1061. https://doi.org/10.1016/j.jtcvs.2011.02.009
  18. Oslopov VN, Bogayavlenskaja OV. The body shape index is a new indicator of the risk of premature death. Kazanskii meditsinskii zhurnal. 2015;96(2):253-256. (In Russ.). https://doi.org/10.17750/KMJ2015-253
  19. Johson AP, Parlov JL, Whitehead M, Xu L, Rohland S, Milne B. Body mass index, outcomes, and mortality following cardiac surgery in Ontario. Canada. J Am Heart Assoc. 2015;4:e00240. https://doi.org/10.1161/JAHA.115.002140
  20. Dedov İİ, Melnichenko GA, Shestakova MV, Troshina EA, Mazurina NV, Shestakov EA, Yashkov YuU., Neimark AE. Russian national clinical recommendations for morbid obesity treatment in adults. 3-rd revision (Morbid obesity treatment in adults). Ozhirenie i metabolizm. 2018;15(1):53-70.  https://doi.org/10.14341/OMET2018153-70
  21. Sedov VM, Fishman MD, Kuprin PE, Solovyeva MO. Complex approach to the treatment of bariatric patients. Al’manakh Instituta khirurgii im. A.V. Vishnevskogo. 2012;7(1):130-131 (In Russ.).
  22. Levy P, Fried M, Santini F, Finer N. The comparative effects of bariatric surgery on weight and type 2 diabetes. Obes Surg. 2007;17:1248-1256. https://doi.org/10.1007/s11695-007-9214-z
  23. Buchwald H, Oien DM. Metabolic bariatric surgery world wide 2011. Obes surg. 2013;23(4):427-436. 
  24. Busetto L, Sbraccia P, Frittitta L, Pontrioli AE. The growing role of bariatric surgery in the management of type 2 diabetes evidences and open questions. Obes Surg. 2011;21:1451-1457. https://doi.org/10.1007/s11695-011-0471-5
  25. Schaner PR, Kashyar SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE, Thomas S, Abood B, Nissen SE, Bhatt DL. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. New Engl J Med. 2012;366(17):1567-1576. https://doi.org/10.1056/NEJMOA1200225
  26. Doggrell SA, Chan V. Bariatric surgery or medicine for type 2 diabetes. Expert opin Pharmacother. 2012;13615:2249-2253. https://doi.org/10.1517/14656566.2012.721779
  27. Fishman MD, Sedov VM, Kuprin PE, Sovolyeva MO, Muzhikov SP. Laparoscopic bariatric and plastic surgeries for metabolic disorders. Endosckopicheskaya khirurgiya. 2010;6:14-18. (In Russ.).
  28. Diamentis Th, Apostolon KG, Alexandron A, Griniatsos J, Tsigris Ch. Review of long-term weight loss results after laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2014;10(1):177-183.  https://doi.org/10.1016/j.soard.2013.11.007
  29. Lee WK, Kim SM. Three-year experience of pouch dilatation and slipage management after laparoscopic adjustable gastric banding. Yansei Med J. 2014;2010;55(1):146-156.  https://doi.org/10.3349/ymj.2014.55.1.149
  30. Sammour T, Hill AG, Singh P, Ranasinghe A, Babor R, Rahman H. Laparoscopic sleeve gastrectomy as a single-stage bariatric procedure. Obes Surg. 2010;20:271-275.  https://doi.org/10.1007/s11695-009-0038-x
  31. Fishman MB, Van Yan, Sokolova DA. Possible reasons of insufficient efficacy of laparoscopic gastric bypass in surgical treatment of metabolic. Vestnik khirurgii. 2017;176:43-49. (In Russ.).
  32. Lopez-Tomasetti-Fernandez EM, Hernandez JR, Nunez JV. Laparoscopic biliopancreatic diversion: a surgical technique in our learning curve. Cir Esr. 2011;89(6):362-369.  https://doi.org/10.1016/j.ciresp.2011.02.010
  33. Angrisani L, Santonicola A, Hasani A, Nosso G, Capaldo B, Iovino: five-year results of laparoscopic sleeve gastrectomy: effects on gastroesophageal reflux disease symptoms and co-morbidities. Surg Obes Relat Dis. 2016;12:960-968.  https://doi.org/10.1016/j.soard.2015.09.014
  34. Desiderio J, Trastulli S, Scalercio V, Cirocchi R, Carloni G, Moriconi E, Boselli C, Noya G, Parisi A. Laparoscopic sleeve gastrectomy and medical management for the treatment of type 2 diabetes melliyus in non-morbidly obese patients: a single — center experience. Diabetes Technol Ther. 2013;15(4):281-288.  https://doi.org/10.1089/dia.2012.0308
  35. Hirth DA, Jones EL, Rothchild KB, Mitchell BC, Schoen JA. Laparoscopic sleeve gastrectomy: long-term weight loss outcomes. Surg Obes Relat Dis. 2015;11:1004-1007. https://doi.org/10.1016/j.soard.2015.02.016
  36. Pirolla EH, Jureidini R, Barbosa UL, Ishikawa LC, Camargo PR. A modified laparoscopic sleeve gastrectomy for the treatment of diabetes mellitus type 2 and metabolic syndrome in obesity. Am J Surg. 2012;203(6):785-792.  https://doi.org/10.1016/j.amjsurg.2011.08.014
  37. Trastulli S, Desiderio J, Guarino S, Cirocchi R, Scalercio V, Noya G, Parisi A. Laparoscopic sleeve gastrectomy compared with other bariatric surgical procedures: a systematic review of randomized trials. Surg Obes Relat Dis. 2013;9(5):816-829.  https://doi.org/10.1016/j.soard.2013.05.007
  38. Schou CF, Aasheim ET, Kristinsson J. Treating morbid obesity with laparoscopic biliopancreatic diversion with duodenal switch. Tidsskr Nor Laegeforen. 2011;131(19):1882-1886. https://doi.org/10.4045/tidsskr.10.1164
  39. Felsenreich DM, Langer FB, Kefurt R, Attit Baskota. Weight loss, weight regain and conversions to Roux-en-Y gastric bypass-10-year result of laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2016;12:1651-1654. https://doi.org/10.1016/j.soard.2016.02.021
  40. Harsha V, Pankaj J. Pasricha. Botulinum Toxin for Gastrointestinal Disorders. Therapy and Mechanisms. Neurotoxicity Res. 2006;9:149-159.  https://doi.org/10.1007/BF03033934
  41. Lee JH, Kim CG, Kim YW, Choi IJ, Lee JY, Cho SJ, Kim YI, Eom BW, Yoon HM, Ryu KW. Botulinum Toxin Injection for the Treatment of Delayed Gastric Emptying Following Pylorus-Preserving Gastrectomy: an Initial Experience. J Gastric Cancer. 2017;17(2):173-179.  https://doi.org/10.5230/jgc.2017.17.e18
  42. Gui D, Gaetano A, Spada PL, Viggiano A, Cassetta E, Albanese A. Botulinum toxin injected in the gastric wall reduces body weight and food intake in rats. Aliment Pharmacol Ther. 2000;14(6):829-834.  https://doi.org/10.1046/j.1365-2036.2000.00765.x
  43. Gui D, Mingrone G, Valenza V, Spada PL, Mutignani M, Runfola M, Scarfone A, Di Mugno M, Panunzi S. Effect of botulinum toxin antral injection an gastric emptying and weight reduction in obese patients: a pilot study. Aliment Pharmacol Ther. 2006;23(5):675-680.  https://doi.org/10.1111/j.1365-2036.2006.02773.x
  44. Pirazzini M, Rossetto O, Eleopra R, Montecucco C. Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology. Pharmacol Rev. 2017;69:200-235.  https://doi.org/10.1124/pr.116.012658
  45. Pero R, Coretti L, Lembo F. Botulinum Toxin A for Controlling Obesity. Toxins. 2016;8(10):281.  https://doi.org/10.3390/toxins8100281
  46. Ahmed SS, Sherpa G, Ahmed AR, Ahmed S. Intragastric Botolinum Toxin-A Injection as a Treatment for Obesity in Comparison to Gastric Balloon. Obes Surg. 2016;26(9):11.  https://doi.org/10.1007/s11695-016-2305-y
  47. Coskun H, Yasin D, Ece D, Mehmet M, Hulya S, Mehmet OD. Effect on Gastric Emptying and Weight Reduction of Botulinum Toxin-A Injection into the Gastric Antral Layer. An Experimental Study in the Obese Rat Model. Obes Surg. 2005;15:1137-1143. https://doi.org/10.1381/0960892055002275
  48. Mittermair R, Keller Ch, Geible J. İntragastric injection of botulinum toxin a for the treatment of obesity. Obesity Surg. 2007;17:732-736.  https://doi.org/10.1007/s11695-007-9135-x
  49. Cerfolio RJ, Bryant AS, Canon CL, Dhawan R, Eloubeidi MA. Is botulinum toxin injection of the pylorus during Ivor-Lewis esophagogastrectomy the optimal drainage strategy? J Thor Cardiovasc Surg. 2009;137(3):565-572.  https://doi.org/10.1016/j.jtcvs.2008.08.049
  50. Bai Y, Xu MJ, Yang X, Xu C, Gao J, Zou DW, Li ZS. A systemic review on intrapyloric botulinum toxin injection for gastroparesis. Digestion. 2010;81(1):27-34. 
  51. Garcia-Compean D, Mendoza-Fuerte E, Martinez JA, Villarreal I, Maldonado H. Endoscopic injection of botulinum toxin in the gastric antrum for the treatment of obesity. Results of a pilot study. Gastroenterol Clin Biol. 2005;29(8-9):789-791.  https://doi.org/10.1016/s0399-8320(05)86349-3
  52. Topazian M, Camilleri M, Mora-Levy JDL, Felicity BE, Foxx-Orenstein AE, Levy MJ, Nehra V, Nicholas JT. Endoscopic Ultrasound-Guided Gastric Botulinum Toxin Injections in Obese Subjects: A Pilot Study. Obes Surg. 2008;18(4):401-407.  https://doi.org/10.1007/s11695-008-9442-x
  53. James AN, Ryan JP, Parkman HP. İnhibitory effects of boyulinum toxin on pyloric and antral smooth muscle. Am J Physiol Gastrointest Liver Physiol. 2003;285:291-297.  https://doi.org/10.1152/ajpgi.00296.2002
  54. Chan SS. Endoscopic botulinum toxin injection. Benefit and limitation 2014. Society of Gastrointestinal Intervention. 2014;3(1):19-23.  https://doi.org/10.1016/j.gii.2014.03.001
  55. Shahnazarian V, Ramai D, Sarkar A. Endoscopic bariatric therapies for treating obesity: a learning curve for gastroenterologists. Transl Gastroenterol Hepatol. 2019;4:16.  https://doi.org/10.21037/tgh.2019.03.01
  56. Nimeri A, Zaman MB, Maasher A, İbrahim M, Salim E. Endoscopic intra-gastric botulinum toxin injection for obesity leading to total gastrectomy and Roux en Y esophago-jejunostomy. Surg Obes Related Dis. 2016;12(7):116.  https://doi.org/10.1016/j.soard.2016.08.181
  57. Bjorkman DJ. Bang C.S. Intragastric Botulinum Toxin Injection for Obesity. Gastrointest Endosc. 2015; March 9.  https://doi.org/10.1016/j.gie.2014.12.025
  58. Torralvo S, Hernandez V, Tapia MJ, Fernandez A, Olveira G. Intragastric injection of botulinum toxin. A real alternative for obesity treatment? A systemic review. Nutricion hospitalaria. 2017;34(5):1482-1488. https://doi.org/10.20960/nh.1220
  59. Elshakh H, El-Ejji K, Taheri S. The role of endoscopic Intra-gastric botulinum toxin-A for obesity treatment. Obes Surg. 2017;9:2471-2478.
  60. Maurizio O, Enrico M, Francesco M, Caterina N, Alessandra V, Cristina B, Fabio C, Diego F. Claudio M. Botulinum neurotoxin-A does not spread to distant muscules after intragastric injection: a double-blind single-fiber electromyography study. Muscle Nerve. 2011;43(3):452-453.  https://doi.org/10.1002/mus.21662
  61. Nimeri A, Zaman MB, Maasher A, İbrahim M, Salim E, Al Shaban T. Endoscopic intra-gastric botulinum toxin injection for obesity leading to total gastrectomy and Roux en Y esophago-jejunostomy. Surg Obes Related Dis. 2016;12(7):116.  https://doi.org/10.1016/j.soard.2016.08.181
  62. Garcia-Compean D, Garza HM. Intragastric injection of botulinum toxin for the treatment of obesity. Where are we? World J Gastroenterol. 2008;14(12):1805-1809. https://doi.org/10.3748/wjg.14.1805
  63. Albani G, Petroni ML, Mauro A, Liuzzi A, Lezzi G, Verti B, Marzullo P, Cattani L. Safety and efficacy of therapy with botulinum toxin in obesity: A pilot study. J Gastroenterol. 2005;40:833-835.  https://doi.org/10.1007/s00535-005-1669-x
  64. Junior AC, Savassi-Rocha PR, Coelho LGV, Sposito MM, Albuquerque W, Diniz M. Botulinum A toxin injected into the gastric wall for the treatment of Class III obesity. A pilot Study. Obes Surg. 2006;16(3):335-343.  https://doi.org/10.1381/096089206776116408
  65. Foschi D, Corsi F, Lazzaroni M, Sangaletti O, Riva P, La Tartara G, Bevilacqua M, Osio M, Alciati A, Bianchi PG, Trabucchi E. Treatment of morbid obesity by intraparietogastric administration of botulinum toxin: a randomized, double-blind, controlled study. Int J Obes (Lond). 2007;31(4):707-712.  https://doi.org/10.1038/sj.ijo.0803451
  66. Li L, Liu QS, Liu WH, Yang YS, Peng LH, Li LY, Meng JY, Wang XD, Ke M. Treatment of obesity by endoscopic gastric intramural infection of botulinum toxin-A: a randomized clinical trial. Hepatogastroenterology. 2012;59(2003-2007). https://doi.org/10.5754/hge11755
  67. Topazian M, Camilleri M, Enders FT, Jonathan EC, Ferga CG, Michael JL, Elizabeth R, Vandana N, Ross AD, Collazo-Clavell ML, Nicholas JT, Matthew MC. Gastric Antral Injections of Botulinum Toxin Delay Gastric Emptying but Do Not Reduce Body Weight. Clin Gastroenterol Hepatol. 2013;11(2):145-150.e1.  https://doi.org/10.1016/j.cgh.2012.09.029
  68. De Moura EG, Bustamante FA, Bernardo WM. Reviewing the reviewers: critical appraisal of «Effect of intragastric injection of botulinum toxin A for the treatment of Obesity: a meta-analysis and meta-regression». Gastrointest Endosc. 2016;83(2):478.  https://doi.org/10.1016/j.gie.2015.08.029
  69. Chang SB, Gwang HB, In SS, Jin BK, Ki TS, Jai HY, Yeon SK, Dong JK. Effect of intragastric injection of botulinum toxin A for the treatment of obesity: a meta-analysis and meta-regression. Gastrointest Endosc. 2015;81(5):1141-1149. https://doi.org/10.1016/j.gie.2014.12.025
  70. Bustamante F, Brunaldi VO, Bernardo WM, de Moura DTH, de Moura ETH, Galvao M, Santo MA, de Moura EGH. Obesity treatment with botulinum toxin A is not effective: a systemic review and meta-analysis. Obes Surg. 2017;27(10):2716-2723.
  71. Bang CS, Baik GH, Suk KT, Yoon JH, Kim JB, Kim DJ. Effect of intragastric injection of botulinum toxin A for the treatment of obesity: A meta-analysis and meta-regression. Gastrointest Endosc. 2015;81(5):1141-1149. https://doi.org/10.1016/S0016-5085(15)32260-5
  72. Sanchez Torralvo FJ, Valdes Hernandez S, Taria MJ, Abuin Fernandez J, Olveira G. İntragastric injection of botulinum toxin. A real alternative for obesity treatment? A systematic review/nutrition. Hospitalaria. 2017;34(5):1482-1488. https://doi.org/10.20960/nh.1220
  73. Park JS, Zheng HM, Kim JM, Kim CS, Jeong S, Lee DH. The effect of intragasttic administration of botulinum toxin type A in reducing adiposity in a rat model of obesity using micro-CT and histological examinations. Gutliver. 2017;11(6):798-806.  https://doi.org/10.5009/gnl16557
  74. De Moura E, Ribeiro I, Frazao M, Mestieri LH, De Moura DT, Dal Bo CM, Brunaldi VO, De Moura ET. EUS-guided intragastric injection of botulinum toxin A in the preoperative treatment of super-obese patients: a randomized clinical trial. Obes Surg. 2019;29(1):32-39.  https://doi.org/10.1007/s11695-018-3470-y
  75. Gameel A, Bahgat M, Seif S, Habeeb M, El-Ghany MA, Altonbary A. Evaluation of endoscopic ultrasoundguided gastric botulinum toxin injections in the treatment of obesity. Egyptian J Int Med. 2020;32(32):29.  https://doi.org/10.1186/s43162-020-00027-8
  76. Chang PC, Jhou HJ, Chen PH, Huang CK, Chiang HH, Chen KH, Chang TW. Intragastric botulinum toxin A injection ls an effective obesty therapy for patients with BMI >40 kg/m2: a systematic review and meta-analysis. Obes Surg. 2020;30(10):4081-4090. https://doi.org/10.1007/s11695-020-04842-4
  77. Torralvo FJS, Pedreno LV, Marin MG, Tapia MJ, Lima F, Fuentes EG, Garcia P, Ruiz JM, Canete AR. Endoscopic intragastric injection of botulinum toxin A in obese patients on bariatric surgery waiting lists: a randomized double-blind study (Intra Tox study). Clin Nurt. 2021;40(4):1834-1842. https://doi.org/10.1016/j.clnu.2020.10.008

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register


We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.